Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine chemoprophylaxis in high-risk healthcare professionals for prevention of SARS-CoV-2 infection
RBR-7bxhrtPhase 3Recruiting
- Sponsor
- Instituto René Rachou
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chloroquine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Instituto René Rachou. Primary endpoint: Prevention of SARS-CoV-2 infection. Started May 2020; status: recruiting.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-7bxhrt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7bxhrt.